Q3 2023 Holdings
Filed 2023-11-15 | 41 holdings | $307.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $54.5M | 3,795,000 | 17.7% |
| Acelyrin Inc | COM | 00445A100 | $42.2M | 4,146,138 | 13.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $20.3M | 6,468,000 | 6.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $15.8M | 1,890,000 | 5.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $15.0M | 653,000 | 4.9% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $14.1M | 1,205,000 | 4.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $11.5M | 360,400 | 3.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $11.4M | 439,000 | 3.7% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $11.0M | 370,000 | 3.6% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $10.1M | 2,430,270 | 3.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.4M | 311,500 | 2.7% |
| Morphosys AG | SPONSORED ADS | 617760202 | $8.1M | 1,209,380 | 2.6% |
| Tela BIO Inc(TELA) | COM | 872381108 | $6.0M | 750,000 | 2.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.0M | 875,405 | 1.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.8M | 500,000 | 1.6% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $4.7M | 584,000 | 1.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.6M | 90,000 | 1.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $4.5M | 2,692,594 | 1.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.5M | 320,000 | 1.5% |
| Geron Corp(GERN) | COM | 374163103 | $4.1M | 1,915,000 | 1.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.0M | 4,754,200 | 1.3% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $3.9M | 308,500 | 1.3% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $3.9M | 274,500 | 1.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.7M | 1,705,900 | 1.2% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.6M | 570,700 | 1.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $3.4M | 848,500 | 1.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $3.1M | 441,896 | 1.0% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $3.1M | 8,000,000 | 1.0% |
| Biodesix | COM | 09075X108 | $3.0M | 455,573 | 1.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.8M | 610,000 | 0.9% |
| Applied Therapeutics(APLT) | COM | 03828A101 | $2.2M | 893,000 | 0.7% |
| IGM Biosciiences Inc(1K0) | COM | 449585108 | $2.2M | 261,000 | 0.7% |
| Codexis Inc(CDXS) | COM | 192005106 | $2.1M | 1,118,900 | 0.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.7M | 211,400 | 0.6% |
| Precigen Inc(PGEN) | COM | 74017N105 | $1.3M | 928,500 | 0.4% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $848.1K | 4,764,508 | 0.3% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $725.4K | 390,000 | 0.2% |
| Fortress Biotech Inc | COM | 34960Q109 | $580.6K | 2,000,000 | 0.2% |
| Kezar Life Sciences Inc | COM | 49372L100 | $505.8K | 425,000 | 0.2% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $90.0K | 30,000 | 0.0% |